Skip to main content

WRF’s president & CEO Orin Levine speaking at InAWH’s inaugural convening on October 9 >>

About Us
Grants
Startup Investments
- Investing in Washington
- Active Portfolio & Exits
Stories
- Stories
- Videos
News
- Articles
- Reports
Contact

Keywords:

Seattle biotech startup secures $11.2M to make drugs for ‘undruggable’ disease targets

Post navigation

← Alpenglow Biosciences lands new contracts to develop 3D pathology tech Allen Institute scientists awarded $1 million to research gene therapy for Dravet syndrome →

Comments are closed.

Home
Contact
LinkedIn

About Us

Grants

Startup Investments
- Investing in Washington
- Active Portfolio & Exits

News
- Articles
- Stories
- Videos

Washington Research Foundation is committed to supporting and welcoming a broad pool of researchers, board members and staff who represent a range of perspectives. We encourage people from all communities to apply for our employment, grantmaking and investment opportunities.

© 2026 Washington Research Foundation, Seattle WA

Terms of Use
Privacy Policy
(206) 336-5600
Site by The Medium

About Us
Grants
Startup Investments
- Investing in Washington
- Active Portfolio & Exits
Stories
- Stories
- Videos
News
- Articles
- Reports
Contact